Investing in Global Health

The transcript discusses the ongoing efforts to address the COVID-19 pandemic, focusing on the development of diagnostics, therapeutics, and vaccines. It highlights the role of the Gates Foundation and other entities in funding and supporting these initiatives. The conversation covers the importance of widespread testing, the challenges faced in different regions, and the need for global access to treatments. It also addresses the incentives for pharmaceutical companies and the timeline for vaccine development, emphasizing the need for preparedness for future waves of infection.

What are the potential risks associated with vaccine development mentioned in the text?

How might the pandemic lead to waves of infection in the future?

What strategies are being considered to ensure the accessibility and affordability of therapeutics and vaccines?

What are the expected priorities for government and industry during the shelter-in-place period?